SG3 Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

SG3 Management’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,101	Closed	-$81K	–	1436
2021 Q1	$81K	Sell	8,101 -16,199	-67%	-$172K	﹤0.01%	1066
2020 Q4	$255K	Buy	+24,300	New	+$254K	﹤0.01%	834

Other funds holding MTACU

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

SG3 Management's MTACU Position: Q2 2021 in Review

SG3 Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q2 2021, closing a stake of 8,101 shares — an estimated $81K sold.

SG3 Management first reported a position in MTACU in Q4 2020 and held it in 2 quarters. The position peaked at $255K in Q4 2020. 30 funds tracked by Wall St. Rank hold MTACU as of Q2 2021.

SG3 Management reported no remaining MedTech Acquisition Corporation Unit position as of Q2 2021 after selling out during the quarter.
SG3 Management sold 8,101 MedTech Acquisition Corporation Unit shares in Q2 2021, an estimated $81K.
SG3 Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 2 quarters.
SG3 Management's MedTech Acquisition Corporation Unit position peaked at $255K in Q4 2020.
30 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.